Moore Capital Management, LP Acadia Pharmaceuticals Inc Transaction History

Moore Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $6.33 Million - $9.37 Million	-200,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $1.51 Million - $2.14 Million	-41,653 Reduced 17.24%	200,000 $8.56 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $481,574 - $953,828	-21,673 Reduced 8.23%	241,653 $8.7 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $1.03 Million - $1.24 Million	-44,124 Reduced 14.35%	263,326 $7.04 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $4.97 Million - $8.42 Million	307,450 New	307,450 $8.26 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.